
All-atom diffusion-based generative model developed for de novo design of protein and peptide binders across a wide array of target types

Protein binder design pipeline that can be used to design miniprotein and peptide binders

A flexible de novo binder design workflow using RFdiffusion for backbone generation
id: noble-bat-topaz

IL-7Ra
Strong
1.4e-9 M
True
12.5 kDa
119
id: lunar-zebra-topaz

EGFR
Strong
1.9e-9 M
True
25.9 kDa
241
id: brisk-boar-cloud

MDM2
Strong
1.7e-7 M
True
12.1 kDa
102
id: golden-cobra-iron

IFNAR2
Medium
5.7e-8 M
True
11.1 kDa
92
Adaptyv Bio • 13 days ago
Experimental validation results for 1,030 protein designs targeting the deadly Nipah virus, yielding 99 binders (26 single-digit nM) with associated developability metrics.





+1025

Massachusetts Institute of Technology • 3 months ago
To validate BoltzGen in its initial preprint release, 422 designed proteins were experimentally tested against 14 distinct targets.





+417

Cradle • 4 months ago
12 EGFR binders designed by Cradle for the Adaptyv 2024 protein design competition, generated through Cradle's zero-shot diversification pipeline.





+7
protein

1030
Proteins validated
103
Binders
Nipah Virus Glycoprotein G mediates viral attachment to host cells. Changes in its expression or function can influence viral spread and disease severity.
protein

826
Proteins validated
134
Binders
Epidermal Growth Factor Receptor (EGFR) regulates cell growth and differentiation. Alterations in its activity are linked with cancer progression and treatment resistance.
protein
103
Proteins validated
0
Binders
Human Serum Albumin
other

97
Proteins validated
62
Binders
IL-7Ra is a receptor critical for the development and homeostasis of immune cells. Altered levels of IL-7Ra are associated with immune deficiencies and autoimmune disorders.



Proteinbase brings together protein designs, experimental results, and design methods in one place to share, compare, and learn.